Puas yog INR siab txhais tau tias los ntshav lossis txhaws?


Sau: Succeeder   

INR feem ntau yog siv los ntsuas cov nyhuv ntawm qhov ncauj anticoagulants hauv kab mob thromboembolic.Ntev INR yog pom nyob rau hauv qhov ncauj anticoagulants, DIC, vitamin K deficiency, hyperfibrinolysis thiab hais txog.Ib qho luv luv INR feem ntau pom hauv cov xeev hypercoagulable thiab mob thrombotic.INR, tseem hu ua International Normalized Ratio, yog ib qho ntawm cov coagulation muaj nuj nqi kuaj cov khoom.INR yog raws li PT reagent los ntsuas lub International Sensitivity Index thiab xam cov txiaj ntsig los ntawm cov qauv sib xws.Yog tias INR siab heev, muaj kev pheej hmoo ntawm cov ntshav uas tswj tsis tau.INR tuaj yeem saib xyuas thiab siv cov nyhuv ntawm cov tshuaj anticoagulant.Feem ntau, cov tshuaj anticoagulant warfarin yog siv, thiab INR yuav tsum tau saib xyuas txhua lub sijhawm.Koj yuav tsum paub tias yog siv warfarin, INR yuav tsum tau saib xyuas tsis tu ncua.Cov neeg mob venous thrombosis yuav tsum noj tshuaj warfarin hauv qhov ncauj, thiab feem ntau tus nqi INR yuav tsum khaws cia ntawm 2.0-2.5.Rau cov neeg mob atrial fibrillation, tus nqi ntawm qhov ncauj warfarin feem ntau khaws cia ntawm 2.0-3.0.INR qhov tseem ceeb tshaj 4.0 tuaj yeem ua rau tsis tuaj yeem los ntshav, thaum INR cov nqi qis dua 2.0 tsis muab cov tshuaj tiv thaiv zoo.

Tswv yim: tseem mus rau lub tsev kho mob tsis tu ncua rau kev kuaj mob, thiab ua raws li kev npaj ntawm tus kws kho mob.

Beijing Succeeder tshwj xeeb hauv thrombosis thiab hemostasis kuaj cov khoom lag luam thoob ntiaj teb.

Raws li ib qho ntawm cov khoom lag luam hauv Tuam Tshoj Diagnostic lag luam ntawm Thrombosis thiab Hemostasis .SUCCEEDER tau ntsib pab pawg ntawm R&D, Kev Tsim Khoom, Kev Muag Khoom thiab Kev Pabcuam Muab cov coagulation analyzers thiab reagents, ntshav rheology analyzers ESR thiab HCT analyzers platelet aggregation analyzers nrog ISO13485 thiab FDACE npe.